A Study of TQB2450 Injection Combined With Anlotinib Hydrochloride Capsule Versus Paclitaxel for Injection (Albumin Bound) in Subjects With Triple Negative Breast Cancer (TNBC)
Clinical trial NCT04405505 · UNKNOWN
Trial details
- NCT number
- NCT04405505
- Sponsor
- Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-06-01
- Primary completion
- 2022-07-01
- Enrollment
- 332
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.